Latest return on equity
Coherus Oncology Return on equity
Coherus Oncology (CHRS) return on equity with its verified observation date.
Direct answer
Coherus Oncology's return on equity is -178.39%.
The verified market snapshot reports -178.39%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 2, 2026.
Get free Coherus Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -178.39%
Explore related company data
View Coherus Oncology's market capitalizationView Coherus Oncology's price-to-book ratioView Coherus Oncology's 52-week price rangeView Coherus Oncology's revenue growthView Coherus Oncology's profit marginView Coherus Oncology's debt-to-equity ratioView all Coherus Oncology key metricsReturn to Coherus Oncology profile